Recently, a new coronavirus disease (COVID-19) has emerged as a respiratory infection with significant concern for global public health hazards. With an initial suspicion of the animal to the human transmission for earlier cases, now the paradigm has shifted towards human to human transmission via droplets, contacts and/or through fomites. with each passing day, more and more confirmed cases are being reported worldwide which has alarmed the global authorities including World Health Organization (WHO)

In December 2019, a new type of Coronavirus that causes pneumonia was first detected in Wuhan, China, and is since then spreading worldwide.

Backgrounds: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date.

Since the first cases of pneumonia of an unknown origin were identified in Wuhan, the capital city of Hubei province, China in December 2019, Chinese scientists have urgently and persistently worked to determine the causative agent.

The coronavirus disease 2019 (COVID-19) from Wuhan, China has become a global challenge since the late December 2019.

Since December, 2019, a 2019 novel coronavirus disease (COVID-19) infected by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in Wuhan, Hubei province, and the epidemic situation has continued to spread globally.

In December 2019, the 2019 novel coronavirus (2019-nCoV) was identified in the viral pneumonia cases occurredin Wuhan, Hubei Province, China; In the following month,the 2019-nCoV quickly spreading inside and outside of Hubei Province and even other countries. Respiratory droplet transmission is the main route of transmission, while it can also be transmitted through contact.

Background: The newly identified 2019-nCoV, which appears to have originated in Wuhan, the capitalcity of Hubei province in central China, is spreading rapidly nationwide. A number of cases of neonates born to mothers with 2019-nCoV pneumonia have been recorded. However, the clinical features of these cases have not been reported, and there is no sufficient evidence for the proper prevention and control of 2019-nCoV infections in neonates.

Two decades after the severe acute respiratory syndrome (SARS), and one decade after the middle east respiratory syndrome (MERS), a new outbreak of respiratory illness sustained by a member of the coronavirus (CoV) family has been first identified in Wuhan (Hubei Province, China), and is rapidly spreading around the world.

Since December 2019, there has been an outbreak of novel coronavirus (2019-nCoV) infectionin China. Two cases of neonates with positive 2019-nCoV tests have been reported.

Background: The coronavirus disease 2019 (COVID-19) outbreak originating in Wuhan, Hubei province, China, coincided with chunyun, the period of mass migration for the annual Spring Festival. To contain its spread, China adopted unprecedented nationwide interventions on January 23 2020.

The alarmingly contagious coronavirus disease 2019 (COVID-19) outbreak occurred in Wuhan in December 2019. In response to the call of China’s National Health Commission, the Second Xiangya Hospital (SXYH) of Central South University has sent out 4 teams (with a total of 192 members) to Wuhan to fight directly against the epidemic (1).

COVID-19 has become a global hotspot (1,2). We report a case of COVID-19 with no sign of viral pneumonia but initially confirmed as myocarditis by SARS-CoV-2.